This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_THYROID_PAPILLARY_ADENO_EXALLC for full statistics.
Papillary adenocarcinoma of thyroid gland
C3_THYROID_PAPILLARY_ADENO
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Cause of death: ICD-10
C73.91&
Cause of death: ICD-9
193A
Cancer registry: Topography ICD-O-3
C73
Cancer registry: Morphology ICD-O-3
8260
Cancer registry: Behaviour codes
3
2 out of 7 registries used, show all original rules.
1433
Check minimum number of events None
1433
Include endpoints None
1433
Remove individuals based on genotype QC
1386
C3_THYROID_PAPILLARY_ADENO
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF8
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to
Papillary adenocarcinoma of thyroid gland
based on the number of shared cases.
Broader endpoints:
- Papillary adenocarcinoma of thyroid gland (controls excluding all cancers)
- Malignant neoplasm of thyroid gland (controls excluding all cancers)
- Malignant neoplasm of thyroid gland
- Malignant neoplasm of endocrine gland
- Malignant neoplasm of endocrine gland (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1386 | 1054 | 332 |
| Unadjusted prevalence (%) | 0.37 | 0.50 | 0.20 |
| Mean age at first event (years) | 49.40 | 47.77 | 54.59 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_THYROID_PAPILLARY_ADENO – Papillary adenocarcinoma of thyroid gland
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Papillary adenocarcinoma of thyroid gland
↥Endpoint not on priority list, no data to show.